CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $422,000 | +98.1% | 8,155 | -0.6% | 0.00% | – |
| Q2 2022 | $213,000 | -2.7% | 8,204 | -6.5% | 0.00% | – |
| Q1 2022 | $219,000 | -31.8% | 8,778 | +1.2% | 0.00% | – |
| Q4 2021 | $321,000 | -82.9% | 8,675 | -91.0% | 0.00% | -100.0% |
| Q3 2021 | $1,881,000 | +40.0% | 96,150 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $1,344,000 | -69.4% | 95,209 | +6.3% | 0.00% | -66.7% |
| Q1 2021 | $4,399,000 | -26.2% | 89,554 | -6.3% | 0.00% | -25.0% |
| Q4 2020 | $5,957,000 | +3980.1% | 95,573 | +3766.2% | 0.00% | – |
| Q3 2020 | $146,000 | -34.5% | 2,472 | -34.5% | 0.00% | – |
| Q2 2020 | $223,000 | +4360.0% | 3,775 | +2826.4% | 0.00% | – |
| Q1 2020 | $5,000 | -97.8% | 129 | -97.7% | 0.00% | – |
| Q4 2019 | $223,000 | +829.2% | 5,623 | +57.6% | 0.00% | – |
| Q3 2019 | $24,000 | -96.7% | 3,568 | -95.5% | 0.00% | -100.0% |
| Q2 2019 | $733,000 | -57.3% | 78,890 | -36.2% | 0.00% | 0.0% |
| Q1 2019 | $1,717,000 | +21.9% | 123,643 | -4.2% | 0.00% | 0.0% |
| Q4 2018 | $1,408,000 | -14.8% | 129,083 | -1.2% | 0.00% | 0.0% |
| Q3 2018 | $1,652,000 | +20.5% | 130,682 | +25.5% | 0.00% | 0.0% |
| Q2 2018 | $1,371,000 | +826.4% | 104,104 | +861.4% | 0.00% | – |
| Q1 2018 | $148,000 | +89.7% | 10,828 | -17.5% | 0.00% | – |
| Q4 2017 | $78,000 | -20.4% | 13,132 | 0.0% | 0.00% | – |
| Q3 2017 | $98,000 | -3.9% | 13,132 | +19.4% | 0.00% | – |
| Q2 2017 | $102,000 | -29.2% | 10,994 | -65.7% | 0.00% | – |
| Q2 2016 | $144,000 | +1340.0% | 32,059 | +689.4% | 0.00% | – |
| Q1 2016 | $10,000 | -16.7% | 4,061 | +178.7% | 0.00% | – |
| Q4 2015 | $12,000 | -82.4% | 1,457 | -85.4% | 0.00% | – |
| Q4 2014 | $68,000 | +1600.0% | 10,000 | +1462.5% | 0.00% | – |
| Q2 2014 | $4,000 | – | 640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |